Creator of Nugache Worm Reaches Plea Agreement: related news

Creator of Nugache worm reaches plea agreement

The teenage creator of a botnet who used a clever worm to infect PCs and then steal users' personal data has agreed to a plea deal with federal prosecutors in California.

Creator of Nugache Worm Reaches Plea Agreement

The teenage creator of a botnet who used a clever worm to infect PCs and then steal users' personal data has agreed to a plea deal with federal prosecutors in California.

Creator of Nugache worm reaches plea agreement

The teenage creator of a botnet who used a clever worm to infect PCs and then steal users' personal data has agreed to a plea deal with federal prosecutors in California.

Creator of Nugache Worm Reaches Plea Agreement

The teenage creator of a botnet who used a clever worm to infect PCs and then steal users' personal data has agreed to a plea deal with federal prosecutors in California.

Creator of Nugache Worm Reaches Plea Agreement

Techzonez The teenage creator of a botnet who used a clever worm to infect PCs and then steal users' personal data has agreed to a plea deal with federal prosecutors in California.

Teenage creator of Nugache worm reaches plea agreement

Security management is the process of developing a comprehensive data protection plan. It takes into account all potential threats, the existing network environment, the future needs of the organization, and lays out a multi-tiered blueprint to integrate the security technology needed to combat these threats. CDW can help keep your network and data secure.

Teenage creator of Nugache worm reaches plea agreement

The prosecutor must be crazy! The proposed sentence is not going to be a deterrent to others, or even this...

Altair Nanotechnologies Ships Battery Packs to Phoenix MC, Inc.: Companies Sign New Principles of Agreement Letter

Altair Nanotechnologies Inc. (NASDAQ: ALTI), a leading provider of advanced nanomaterials technology for use in energy, life sciences and industrial applications, today announced that it has signed a new Principles of Agreement Letter with Phoenix Motorcars, Inc. Under the terms of the agreement, Altair will ship 47 battery packs purchased by Phoenix in 2007 to Phoenix for use exclusively in demonstration vehicles. In addition, Altair entered into a letter of agreement with Phoenix formally terminating the existing supply agreement and mutually releasing each other from any claims under such agreement.

Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges

PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) announced today that its Barr Laboratories subsidiary has signed a Settlement Agreement and a License Agreement with Boehringer Ingelheim to resolve the patent litigation involving Boehringer Ingelheim's Mirapex(R) product. Separately, Barr Laboratories entered into a Settlement Agreement and a Supply Agreement to resolve the patent litigation regarding Boehringer Ingelheim's Aggrenox(R) product and Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, entered into a Co-Promotion Agreement with Boehringer Ingelheim relating to Aggrenox(R).

Barr Announces Agreements to Settle Mirapex and Aggrenox Patent Challenges

MONTVALE, N.J., August 12, 2008 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. announced today that its Barr Laboratories subsidiary has signed a Settlement Agreement and a License Agreement with Boehringer Ingelheim to resolve the patent litigation involving Boehringer Ingelheim's Mirapex(R) product. Separately, Barr Laboratories entered into a Settlement Agreement and a Supply Agreement to resolve the patent litigation regarding Boehringer Ingelheim's Aggrenox(R) product and Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, entered into a Co-Promotion Agreement with Boehringer Ingelheim relating to Aggrenox(R).

Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges

MONTVALE, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) announced today that its Barr Laboratories subsidiary has signed a Settlement Agreement and a License Agreement with Boehringer Ingelheim to resolve the patent litigation involving Boehringer Ingelheim's Mirapex(R) product. Separately, Barr Laboratories entered into a Settlement Agreement and a Supply Agreement to resolve the patent litigation regarding Boehringer Ingelheim's Aggrenox(R) product and Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, entered into a Co-Promotion Agreement with Boehringer Ingelheim relating to Aggrenox(R).

Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges

MONTVALE, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL - News) announced today that its Barr Laboratories subsidiary has signed a Settlement Agreement and a License Agreement with Boehringer Ingelheim to resolve the patent litigation involving Boehringer Ingelheim's Mirapex® product. Separately, Barr Laboratories entered into a Settlement Agreement and a Supply Agreement to resolve the patent litigation regarding Boehringer Ingelheim's Aggrenox® product and Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, entered into a Co-Promotion Agreement with Boehringer Ingelheim relating to Aggrenox®.

WORM GEARBOXES AVAILABLE IN 4 FRAME SIZES

ImageAutomationDirect has expanded its mechanical power transmission product line to include worm gearboxes in four frame sizes, and six gear ratios from 5:1 to 60:1. Constructed of cast iron one-piece housings, the worm gearboxes feature a C-flange input and carbon steel shaft with either right-hand or dual shaft output. IronHorse worm gearboxes have double-lipped embedded oil seals to prevent leakage.

Delphi Announces Agreement With Beck Aluminum to Market Delphi's Patented K-Alloy

TROY, MI--(MARKET WIRE)--Aug 6, 2008 -- Delphi Corp. (Other OTC:DPHIQ.PK - News) has announced a strategic licensing agreement with Beck Aluminum to produce and market Delphi's patented corrosion-resistant K-Alloy(TM). The agreement is designed to improve the competitiveness of the product through increased availability at attractive prices. The Delphi agreement with Beck Aluminum helps simplify the process to gain access to the patented material.

Webvigour Software Releases RSS Feed Creator

Webvigour Software has released RSS Feed Creator. Designed for the Windows OS, this application enables you to create, edit, and publish RSS feeds and podcasts. RSS Feed Creator combines a support for various RSS formats, a podcasting support, a WYSIWYG HTML editor, an XML editor, an RSS Feed preview, an FTP upload and publishing, automatic date management, and an ability to convert CSV or HTML to RSS and back. RSS Feed Creator can create and maintain an unlimited number of RSS feeds and podcasts.

DUSA Announces Patent Licensing Agreement

today announced that it has entered into a non-exclusive patent license agreement granting River's Edge Pharmaceuticals, LLC rights for a vitamin-mineral product (nicotinamide, zinc, copper and folic acid) in the prescription market. DUSA is taking this action in light of the entry of generic products in this market and DUSA's need to enforce its intellectual property rights while trying to avoid litigation. DUSA, which previously sold its patented product in this market, now plans to sell its product under the dietary supplement rules as a result of discussions with the Food and Drug Administration. The one-year agreement is subject to an extension under certain terms and conditions and does not include a trademark license. As part of the agreement, DUSA will receive a share of the net revenues River's Edge generates.

Google's Big Mistake - Getting Rid of Google Page Creator

Are you kidding me? Google getting rid of Google Page Creator, this must be a joke. No, it's for real. Google says they're going to be transitioning all Google Page Creator websites into their new Google Sites. Excuse me, but Google Sites doesn't come close to being as good as Google Page Creator. Why in the world would Google choose to keep the lesser of the two?

ACCESS, NTT DOCOMO Conclude Technical Specification Development Agreement for ACCESS Linux Platform

TOKYO, Aug. 8 /PRNewswire/ -- ACCESS CO., LTD., a global provider of advanced software technologies to the mobile and beyond-PC markets, today announced the Company concluded a System Engineering Assistance agreement with NTT DOCOMO, INC. on July 16, 2008. According to the terms of the agreement, ACCESS will create the technical specifications for co-developing an operator pack for ACCESS Linux Platform(TM) for DOCOMO's FOMA(TM) 3G handsets. FOMA (Freedom Of Mobile multimedia Access) is the brand name for NTT DOCOMO's 3G services, and was the world's first W-CDMA 3G service, launched in 2001. The two companies are targeting the conclusion of an agreement detailing software development work for the FOMA operator pack during August.

ACCESS, NTT DOCOMO Conclude Technical Specification Development Agreement for ACCESS Linux Platform

TOKYO, Aug. 8 /PRNewswire/ -- ACCESS CO., LTD., a global provider of advanced software technologies to the mobile and beyond-PC markets, today announced the Company concluded a System Engineering Assistance agreement with NTT DOCOMO, INC. on July 16, 2008. According to the terms of the agreement, ACCESS will create the technical specifications for co-developing an operator pack for ACCESS Linux Platform(TM) for DOCOMO's FOMA(TM) 3G handsets. FOMA (Freedom Of Mobile multimedia Access) is the brand name for NTT DOCOMO's 3G services, and was the world's first W-CDMA 3G service, launched in 2001. The two companies are targeting the conclusion of an agreement detailing software development work for the FOMA operator pack during August.

ACCESS, NTT DOCOMO Conclude Technical Specification Development Agreement for ACCESS Linux Platform

TOKYO, Aug. 8 /PRNewswire/ -- ACCESS CO., LTD., a global provider of advanced software technologies to the mobile and beyond-PC markets, today announced the Company concluded a System Engineering Assistance agreement with NTT DOCOMO, INC. on July 16, 2008. According to the terms of the agreement, ACCESS will create the technical specifications for co-developing an operator pack for ACCESS Linux Platform(TM) for DOCOMO's FOMA(TM) 3G handsets. FOMA (Freedom Of Mobile multimedia Access) is the brand name for NTT DOCOMO's 3G services, and was the world's first W-CDMA 3G service, launched in 2001. The two companies are targeting the conclusion of an agreement detailing software development work for the FOMA operator pack during August.

ACCESS, NTT DOCOMO Conclude Technical Specification Development Agreement for ACCESS Linux Platform

TOKYO, Aug 08, 2008 /PRNewswire via COMTEX/ -- ACCESS CO., LTD., a global provider of advanced software technologies to the mobile and beyond-PC markets, today announced the Company concluded a System Engineering Assistance agreement with NTT DOCOMO, INC. on July 16, 2008. According to the terms of the agreement, ACCESS will create the technical specifications for co-developing an operator pack for ACCESS Linux Platform(TM) for DOCOMO's FOMA(TM) 3G handsets. FOMA (Freedom Of Mobile multimedia Access) is the brand name for NTT DOCOMO's 3G services, and was the world's first W-CDMA 3G service, launched in 2001. The two companies are targeting the conclusion of an agreement detailing software development work for the FOMA operator pack during August.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.

LUXEMBOURG & KALAMAZOO, Mich., BUSINESS WIRE -- ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient. The other terms of the agreement are confidential.

Search took 0.14 seconds.